Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
Díaz Méndez AB, Sacconi A, Tremante E, Lulli V, Caprara V, Rosanò L, Goeman F, Carosi M, Di Giuliani M, Vari G, Silvani A, Pollo B, Garufi C, Ramponi S, Simonetti G, Ciusani E, Mandoj C, Scalera S, Villani V, Po A, Ferretti E, Regazzo G, Rizzo MG. Díaz Méndez AB, et al. Among authors: villani v. J Exp Clin Cancer Res. 2023 Mar 17;42(1):66. doi: 10.1186/s13046-023-02639-8. J Exp Clin Cancer Res. 2023. PMID: 36932446 Free PMC article.
Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.
Vaccaro V, Fabi A, Vidiri A, Giannarelli D, Metro G, Telera S, Vari S, Piludu F, Carosi MA, Villani V, Cognetti F, Pompili A, Marucci L, Carapella CM, Pace A. Vaccaro V, et al. Among authors: villani v. Biomed Res Int. 2014;2014:351252. doi: 10.1155/2014/351252. Epub 2014 May 4. Biomed Res Int. 2014. PMID: 24877084 Free PMC article. Clinical Trial.
Comorbidities in elderly patients with glioblastoma: a field-practice study.
Villani V, Tanzilli A, Telera SM, Terrenato I, Vidiri A, Fabi A, Zucchella C, Carapella CM, Marucci L, Casini B, Carosi M, Oppido PM, Pace A. Villani V, et al. Future Oncol. 2019 Mar;15(8):841-850. doi: 10.2217/fon-2018-0524. Epub 2019 Jan 18. Future Oncol. 2019. PMID: 30656982
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?
Villani V, Fabi A, Tanzilli A, Pasqualetti F, Lombardi G, Vidiri A, Gonnelli A, Molinari A, Cantarella M, Bellu L, Terrenato I, Carosi M, Maschio M, Telera SM, Carapella CM, Cognetti F, Paiar F, Zagonel V, Pace A. Villani V, et al. Future Oncol. 2019 May;15(15):1717-1727. doi: 10.2217/fon-2018-0826. Epub 2019 Apr 12. Future Oncol. 2019. PMID: 30977687
Neurocognitive evaluation in older adult patients affected by glioma.
Tanzilli A, Pace A, Fabi A, Telera S, Vidiri A, Carosi M, Terrenato I, Koudriavtseva T, Boccaletti R, Villani V. Tanzilli A, et al. Among authors: villani v. J Geriatr Oncol. 2020 May;11(4):701-708. doi: 10.1016/j.jgo.2019.06.015. Epub 2019 Jul 2. J Geriatr Oncol. 2020. PMID: 31277954
199 results